Clinical observation of ornithine aspartate combined with naloxone in the treatment of hepatic encephalopathy
[1]Kircheis G, Wettstein M, Dahl S, et a1.Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy[J].Metab Brain Dis, 2002, 17 (4) ∶453-462.
|
[2] 姜静, 龙连波.乙酰谷酰胺联合纳洛酮治疗肝性脑病临床观察[J].中华现代内科学杂志, 2008, 5 (6) ∶550.
|
[3]徐道振.病毒性肝炎临床实践[M].北京:人民卫生出版社, 2006∶293-294.
|
[4]徐国光, 陈良, 巫善明.门冬氨酸鸟氨酸 (瑞甘) 治疗慢性乙型肝炎临床初步报告[J].世界感染杂志, 2006, 6 (1) ∶64-66.
|
[5] 彭继承.门冬氨酸鸟氨酸治疗肝硬化并发肝性脑病临床研究[J].世界感染杂志, 2008, 8 (5) ∶367-369.
|
[6]徐少卿, 郭云莉.纳络酮治疗肝性脑病的临床研究[J].临床肝胆病杂志, 2008, 24 (4) ∶289-290.
|
[1] | Yuanqin DU, Meng WANG, Guochu HUANG, Chun YAO, Ruixi ZHONG, Liangjiang HUANG, Jian XU, Jingjing HUANG, Qinwen TAN, Dewen MAO. Therapeutic effect of retention enema with compound rhubarb decoction on a rat model of minimal hepatic encephalopathy based on bile acid metabolomics[J]. Journal of Clinical Hepatology, 2023, 39(10): 2348-2357. doi: 10.3969/j.issn.1001-5256.2023.10.012 |
[2] | Xuhong YANG, Yong YANG, Minglei WANG, Wenxiao LIU, Wanlong MA, Minxing WANG, Xiangchun DING, Xiaodong WANG. Value of blood ammonia and cholinesterase in the early diagnosis of liver cirrhosis with minimal hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2023, 39(2): 339-344. doi: 10.3969/j.issn.1001-5256.2023.02.013 |
[3] | Liang ZHANG, Hao LI, Shanhong TANG. Thoughts on the diagnosis and treatment of hepatic encephalopathy associated with blood ammonia in liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(12): 2942-2945. doi: 10.3969/j.issn.1001-5256.2023.12.028 |
[5] | Yan Ming. Selection of the diagnostic and therapeutic methods for minimal hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2016, 32(6): 1092-1099. doi: 10.3969/j.issn.1001-5256.2016.06.014 |
[6] | Zhao Kai, Zhang YueXin. Treatment of minimal hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2014, 30(10): 1094-1096. doi: 10.3969/j.issn.1001-5256.2014.10.030 |
[7] | Xu DaHai, Zhang Nan, Gao JinYing, Wu Yang. The therapeutic development of hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2011, 27(2): 218-221. |
[8] | Jiang Hao, Xie Qing. Advances in the diagnosis and treatment of hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2011, 27(10): 1027-1031. |
[9] | Zhang ZhiHong, Ni BingQiang, Chen RiXin. Protective effect of Ornithine Aspartate on chemotherapy of gastrointestinal tumors with HBV infection[J]. Journal of Clinical Hepatology, 2011, 27(2): 148-150+160. |
[10] | Li YuYuan. Treatment of hepatic encephalopathy and minimal hepatic encephalopathy with L-ornitine-L-aspartate[J]. Journal of Clinical Hepatology, 2011, 27(1): 100-102. |
[11] | Wang YuMing, Yan ZeHui. The new concepts on hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2010, 26(6): 568-574. |
[12] | Zhang YiBing, Wang Xia, Zhang ShuQin, Gao ShiShuang, Sun HongGe, Luo XiGang. The monitoring of Ornithine carbamoyltransferase by the rate of speed method and its Diagnositic value in hepatopathy[J]. Journal of Clinical Hepatology, 2010, 26(1): 60-62. |
[18] | Yin HeKun, Li QiXiang, Luo Dan. The clinical study of L-ornithine-L-aspartate combined with SNMC for hepatic encephalopathy of liver cirrhosis[J]. Journal of Clinical Hepatology, 2007, 23(4): 268-269. |
[19] | Zhang GuangShu, Shang QingHua, Xu ChuanZhen, Chen ChongQing, Yan ChengYu. Study on the pathogenesis and treatment of hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2001, 17(4): 241-243. |